Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

XENE - Xenon Pharmaceuticals Inc.


IEX Last Trade
40.12
0   0%

Share volume: 20,503
Last Updated: Tue 24 Dec 2024 03:31:02 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): 0.45%

PREVIOUS CLOSE
CHG
CHG%

$40.12
-2.13
0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023
Report Date 2022-05-10 2022-08-09 2022-11-08 2023-03-01 2023-05-09 2023-08-09
Total revenue 8.766 M 536.000 K 132.000 K 0.000 0.000 0.000
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 8.766 M 536.000 K 132.000 K 0.000 0.000 0.000
    -93.89% -75.37% -100.00% nan% nan%  
Operating expenses 26.135 M 30.851 M 38.260 M 43.331 M 49.051 M 55.624 M
Selling general and admin 6.775 M 8.705 M 8.829 M 8.501 M 9.535 M 11.584 M
Research and development 19.360 M 22.146 M 29.431 M 34.830 M 39.516 M 44.040 M
Total expenses 26.135 M 30.851 M 38.260 M 43.331 M 49.051 M 55.624 M
    18.04% 24.02% 13.25% 13.20% 13.40%  
Operating income -17.369 M -30.315 M -38.128 M -43.331 M -49.051 M -55.624 M
Ebit -17.369 M -30.315 M -38.128 M -43.331 M -49.051 M -55.624 M
Pretax income -20.064 M -31.198 M -37.737 M -36.256 M -41.437 M -47.681 M
    55.49% 20.96% -3.92% 14.29% 15.07%  
Income tax -394.000 K -40.000 K -587.000 K 1.139 M 290.000 K -220.000 K
Net income basic -19.371 M -31.158 M -37.150 M -37.694 M -41.727 M -47.461 M
    -60.85% -19.23% -1.46% -10.70% -13.74%  
Net income -19.371 M -31.158 M -37.150 M -37.694 M -41.727 M -47.461 M
    -60.85% -19.23% -1.46% -10.70% -13.74%